Furthermore, our findings were corroborated by organoid cultures derived from tumor tissues of newly diagnosed patients with NSCLC, further supporting the role of PRMT3 in enhancing radiotherapy resistance (Fig. 1N). This evidence concerns the gene PRMT3 and neoplasm.